Status:
TERMINATED
Ph1 Marinol Interaction Study - Part 1 - 1
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Conditions:
Marijuana Dependence
Eligibility:
All Genders
18-45 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to examine the effects of oral dronabinol tetrahydrocannabinol (THC) on withdrawal symptoms in marijuana dependent volunteers, and evaluate the safety, pharmacokinetics (P...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Must be between the ages of 18 to 45 years of age
- Must be in good general health
- Must meet DSM-IV criteria for marijuana dependence and are non- treatment seekers at the time of study
- Must be able to provide written informed consent
- Must be able to provide 1 marijuana positive urine specimen (\> 50 ng/mL) within the 28-day screening period
- If female and of child bearing potential, must agree to use birth control.
- Exclusion
- Criteria:
- Please contact site for more information.
Exclusion
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
End Date :
March 1 2007
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT00438139
Start Date
March 1 2007
End Date
March 1 2007
Last Update
January 16 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uniformed Services University of Health Science
Bethesda, Maryland, United States, 20814 4799